Company · CIK 0001649904 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
RHYTHM PHARMACEUTICALS, INC. · RYTM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 SForm 4 → | Sep 14, 7:37 pm EDT | David P MeekerPresident and CEO, Director | 50,000 | $102.67 | $5,133,442 | 239,258 | −17.3% | 10b5-1 |
| Sep 14, 2026 MForm 4 → | Sep 14, 7:37 pm EDT | David P MeekerPresident and CEO, Director | 50,000 | $6.05 | $302,500 | 289,258 | — | 10b5-1 |
| Aug 31, 2026 SForm 4 → | Sep 1, 4:22 pm EDT | Hunter C SmithChief Financial Officer | 62,774 | $105.46 | $6,619,913 | 114,024 | −35.5% | 10b5-1 |
| Aug 31, 2026 MForm 4 → | Sep 1, 4:22 pm EDT | Hunter C SmithChief Financial Officer | 57,187 | $25.79 | $1,474,853 | 176,798 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 MForm 4 → | Sep 14, 7:37 pm EDT | David P MeekerPresident and CEO, Director | 50,000 | — | — | 15,431 | — | 10b5-1 |
| Aug 31, 2026 MForm 4 → | Sep 1, 4:22 pm EDT | Hunter C SmithChief Financial Officer | 57,187 | — | — | 3,813 | — | 10b5-1 |